BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 14558949)

  • 1. [Roles of VEGF-C and its receptor Flt-4 in proliferation and metastasis of primary breast cancer].
    Liu F; Zhang YJ
    Ai Zheng; 2003 Oct; 22(10):1053-6. PubMed ID: 14558949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of vascular endothelial growth factor A and C in human breast cancer and their significance].
    Hu SE; Zhang YJ; Cui YM; Zhang HQ
    Ai Zheng; 2005 Sep; 24(9):1076-9. PubMed ID: 16159428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers.
    Gunningham SP; Currie MJ; Han C; Robinson BA; Scott PA; Harris AL; Fox SB
    Clin Cancer Res; 2000 Nov; 6(11):4278-86. PubMed ID: 11106244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lymphangiogenes and location of tumor lymphatic vessels induced by VEGF-C in primary breast carcer].
    Huang JH; Li Y; Liu L; Yang HC; Hai J; Tang LL; Hu TH
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 31(1):36-9, 51. PubMed ID: 16562672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer.
    Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
    Clin Cancer Res; 2003 Nov; 9(14):5313-7. PubMed ID: 14614015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases.
    Yu XM; Lo CY; Chan WF; Lam KY; Leung P; Luk JM
    Clin Cancer Res; 2005 Nov; 11(22):8063-9. PubMed ID: 16299237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of vascular endothelial growth factor and its receptor (Flt-1) in breast carcinoma].
    Wu H; Li Y; Zhu G; Zhang L; Zhang X; He X
    Zhonghua Yi Xue Za Zhi; 2002 May; 82(10):708-11. PubMed ID: 12133473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression and clinical significance of VEGF-C and Flt-4 in tongue squamous cell carcinoma].
    Li QL; Chen FJ; Zeng ZY; Yang AK; Wu QL; Zhang HZ; Hou JH
    Ai Zheng; 2006 Feb; 25(2):235-40. PubMed ID: 16480594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of vascular endothelial growth factor-C and -D mRNA in breast cancer.
    Teramoto S; Arihiro K; Koseki M; Kataoka T; Asahara T; Ohdan H
    Hiroshima J Med Sci; 2008 Jun; 57(2):73-8. PubMed ID: 18717190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of vascular endothelial growth factor-A and -C, and receptors 1 and 3: correlation with lymph node metastasis and prognosis in tongue squamous cell carcinoma.
    Tanigaki Y; Nagashima Y; Kitamura Y; Matsuda H; Mikami Y; Tsukuda M
    Int J Mol Med; 2004 Sep; 14(3):389-95. PubMed ID: 15289890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of vascular endothelial growth factor-C and its receptor-3 messenger RNA with real-time quantitative polymerase chain reaction as a predictor of lymph node metastasis in human colorectal cancer.
    Kawakami M; Furuhata T; Kimura Y; Yamaguchi K; Hata F; Sasaki K; Hirata K
    Surgery; 2003 Mar; 133(3):300-8. PubMed ID: 12660643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between vascular endothelial growth factor-C, its corresponding receptor, VEGFR-3, and prognosis in primary breast cancer: a study with 193 cases.
    Bando H; Weich HA; Horiguchi S; Funata N; Ogawa T; Toi M
    Oncol Rep; 2006 Mar; 15(3):653-9. PubMed ID: 16465426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor-C and its receptor VEGFR-3 in non-small-cell lung cancer: concurrent expression in cancer cells from primary tumour and metastatic lymph node.
    Saintigny P; Kambouchner M; Ly M; Gomes N; Sainte-Catherine O; Vassy R; Czernichow S; Letoumelin P; Breau JL; Bernaudin JF; Kraemer M
    Lung Cancer; 2007 Nov; 58(2):205-13. PubMed ID: 17686546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The balance of VEGF-C and VEGFR-3 mRNA is a predictor of lymph node metastasis in non-small cell lung cancer.
    Takizawa H; Kondo K; Fujino H; Kenzaki K; Miyoshi T; Sakiyama S; Tangoku A
    Br J Cancer; 2006 Jul; 95(1):75-9. PubMed ID: 16755294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEGF-D in association with VEGFR-3 promotes nodal metastasis in human invasive lobular breast cancer.
    van Iterson V; Leidenius M; von Smitten K; Bono P; Heikkilä P
    Am J Clin Pathol; 2007 Nov; 128(5):759-66. PubMed ID: 17951197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between expression of vascular endothelial growth factor C, chemokine receptor CXCR4 and lymph node metastasis in colorectal cancer.
    Fukunaga S; Maeda K; Noda E; Inoue T; Wada K; Hirakawa K
    Oncology; 2006; 71(3-4):204-11. PubMed ID: 17641542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer.
    Zhang XH; Huang DP; Guo GL; Chen GR; Zhang HX; Wan L; Chen SY
    BMC Cancer; 2008 Jan; 8():4. PubMed ID: 18190720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer.
    Nakamura Y; Yasuoka H; Tsujimoto M; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
    Breast Cancer Res Treat; 2005 May; 91(2):125-32. PubMed ID: 15868440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma].
    Lu ZQ; Li HG; Xie DR; Zhang HZ; Shen XM; Zeng YJ; Zeng H
    Ai Zheng; 2005 Sep; 24(9):1132-5. PubMed ID: 16159440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New markers for pharmacological targeting in bladder cancer with lymph node metastasis].
    Herrmann E; Eltze E; Köpke T; Bolenz C; Bierer S; Neumann J; Hertle L; Wülfing C
    Aktuelle Urol; 2007 Sep; 38(5):392-7. PubMed ID: 17907066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.